<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:content="http://purl.org/rss/1.0/modules/content/" version="2.0">
  <channel>
    <title><![CDATA[Dengue]]></title>
    <link>https://www.leadingmarketresearch.com/pharmaceuticals-biotechnology/pharmaceuticals/diseases-conditions/dengue</link>
    <description><![CDATA[Dengue]]></description>
    <pubDate>Sun, 12 Apr 2026 23:14:17 +0000</pubDate>
    <generator>Zend_Feed</generator>
    <docs>http://blogs.law.harvard.edu/tech/rss</docs>
    <item>
      <title><![CDATA[Dengue Fever - Global Clinical Trials Review, H2, 2021]]></title>
      <link>https://www.leadingmarketresearch.com/dengue-fever-global-clinical-trials-review-h2-2021</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p><b>Summary</b><br><br>GlobalData&#039;s clinical trial report, “Dengue Fever - Global Clinical Trials Review, H2, 2021&quot; provides an overview of Dengue Fever Clinical trials scenario. This report provides top line data relating to the clinical trials on Dengue Fever. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma - Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.<br><br>The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.<...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-220383"><span class="price">$2,500.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Fri, 03 Sep 2021 16:07:52 +0000</pubDate>
    </item>
    <item>
      <title><![CDATA[Dengue Fever - Pipeline Review, H1 2018]]></title>
      <link>https://www.leadingmarketresearch.com/dengue-fever-pipeline-review-h1-2018</link>
      <description><![CDATA[<table><tr><td  style="text-decoration:none;"><p><b>Summary</b><br><br>Global Markets Direct&#039;s latest Pharmaceutical and Healthcare disease pipeline guide Dengue Fever - Pipeline Review, H1 2018, provides an overview of the Dengue Fever (Infectious Disease) pipeline landscape.<br><br>Dengue is a mosquito borne infectious disease caused by the dengue virus. Symptoms include a high fever, headaches, joint and muscle pain, vomiting, and a rash. In some cases, dengue turns into dengue hemorrhagic fever, which causes bleeding from nose, gums, or under skin. It can also become dengue shock syndrome, which causes massive bleeding and shock. Treatment includes use of analgesics, fluid replacement therapy and healthy life style.<br><br>Report Highlights<br><br>Global Markets Direct&#039;s Pharmaceutical and Healthcare latest pipeline guide Dengue Fever - Pipeline Review, H1 2018, provides comprehensive information on the therapeutics under development for Dengue Fever (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guid...





        
    <div class="price-box">
                                                            <span class="regular-price" id="product-price-203475"><span class="price">$2,000.00</span></span>
                        
        </div>

</td></tr></table>]]></description>
      <pubDate>Mon, 03 Sep 2018 14:10:02 +0000</pubDate>
    </item>
  </channel>
</rss>
